Theodore R. Schroeder, President, CEO at CADENCE PHARMACEUTICALS INC (CADX), sold 20,000 shares at $10.72 ($214K) on 2009-10-16, disclosed to the SEC on 2009-10-19.
Scheduled sale ($214k) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NBRV | BUY | 2019-08-28 | $90K | — | Filing → |
| CADX | BUY | 2011-05-17 | $120K | — | Filing → |
| CADX | SELL | 2010-10-04 | $418K | — | Filing → |